If a person's cell have the antigen, the antibody should NOT be present in that person's serum. If an antibody to a blood group antigen is present in the serum of a person, his or her cells should lack that antigen. The antigens are on the cells and the antibodies are in the serum.
Therapy-related myeloid leukemia (t-MDS/t-AML) is a well-recognized clinical syndrome occurring as a late complication following cytotoxic therapy.1â5 The term âtherapy-relatedâ leukemia is descriptive and based on a patientâs history of exposure to cytotoxic agents.
Second, AML laws, rules, and orders are subject to change and may change quickly. Statutes that include AML-related provisions may be amended from time to time, and new statutes may be enacted which include AML-related provisions. The information summarized in this guide is current as of May 1, 2012.